Literature DB >> 10677246

Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand.

A Nakajima1, H Hirai, N Kayagaki, S Yoshino, S Hirose, H Yagita, K Okumura.   

Abstract

Since Fas ligand (FasL) can induce apoptosis of Fas-bearing cells, Fas/FasL interactions can play a critical role in maintaining self-tolerance. Fas/FasL interactions in lupus-like autoimmune disease have been well characterized in studies using either Fas or FasL mutant mice. However, the effect of the defective FasL-mediated signaling on the establishment of lupus in other mouse strains, such as NZB/W (B/W) F1, remains uncertain. In the present study, we examined the effect of anti-FasL monoclonal antibody (mAb) on the development of lupus. Treatment of B/W F1 mice with anti-FasL mAb augmented IgG1- and IgG2a-type anti-dsDNA Ab production. However, treatment of B/W F1 mice with anti-FasL mAb also significantly prevented the development of lupus nephritis. These results indicate that Fas/FasL interactions not only regulate IgG-type autoantibody production, but also influence the development of lupus nephritis in B/W F1 mice. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677246     DOI: 10.1006/jaut.1999.0356

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  6 in total

1.  Inhibition of intracellular peroxides and apoptosis of lymphocytes in lupus-prone B/W mice by dietary n-6 and n-3 lipids with calorie restriction.

Authors:  C P Reddy Avula; Richard A Lawrence; Khaliquz Zaman; Gabriel Fernandes
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

Review 2.  Newer drugs for the treatment of lupus nephritis.

Authors:  Dudy G Kuiper-Geertsma; Ronald H W M Derksen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.

Authors:  Lukas Bossaller; Vijay A K Rathinam; Ramon Bonegio; Ping-I Chiang; Patricia Busto; Adam R Wespiser; Daniel R Caffrey; Quan-Zhen Li; Chandra Mohan; Katherine A Fitzgerald; Eicke Latz; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

4.  Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.

Authors:  Li-jun Song; Xiao Wang; Xu-ping Wang; Dong Li; Feng Ding; Hua-xiang Liu; Xiao Yu; Xing-fu Li; Qiang Shu
Journal:  Diagn Pathol       Date:  2015-06-16       Impact factor: 2.644

Review 5.  Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.

Authors:  Anders Tveita; Ole Petter Rekvig; Svetlana N Zykova
Journal:  Arthritis Res Ther       Date:  2008-12-01       Impact factor: 5.156

6.  Transcription factor NFAT1 controls allergic contact hypersensitivity through regulation of activation induced cell death program.

Authors:  Ho-Keun Kwon; Gi-Cheon Kim; Ji Sun Hwang; Young Kim; Chang-Suk Chae; Jong Hee Nam; Chang-Duk Jun; Dipayan Rudra; Charles D Surh; Sin-Hyeog Im
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.